Rein Therapeutics, Inc. Increase (Decrease) in Restricted Cash
Rein Therapeutics, Inc. (RNTX) reported Increase (Decrease) in Restricted Cash of $25.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-04-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-04-02
- Rein Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $0.00.
- Rein Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2016 was $25.00K.
- Rein Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2015 was -$713.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $25.00K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $25.00K 10-Q · filed 2017-11-09 | ||
| 2015-12-31 | -$713.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |